Cenni V, Bavelloni A, Capanni C, Mattioli E, Bortolozzo F, Kojic S
Int J Mol Sci. 2025; 26(4).
PMID: 40004199
PMC: 11855734.
DOI: 10.3390/ijms26041736.
Petrova M, Vlahova Z, Schroder M, Todorova J, Tzintzarov A, Gospodinov A
Pharmaceuticals (Basel). 2023; 16(2).
PMID: 37259331
PMC: 9959655.
DOI: 10.3390/ph16020181.
Grady W, Carethers J
Gastroenterology. 2008; 135(4):1079-99.
PMID: 18773902
PMC: 2866182.
DOI: 10.1053/j.gastro.2008.07.076.
Dey P
J Clin Pathol. 2004; 57(12):1245-9.
PMID: 15563660
PMC: 1770496.
DOI: 10.1136/jcp.2004.018952.
Wiesmuller L
J Biomed Biotechnol. 2002; 1(1):7-10.
PMID: 12488620
PMC: 79672.
DOI: 10.1155/S1110724301000043.
Comparison of the expression of p53, p21, Bax and the induction of apoptosis between patients with basal cell carcinoma and normal controls in response to ultraviolet irradiation.
Murphy M, Mabruk M, Lenane P, Liew A, McCann P, Buckley A
J Clin Pathol. 2002; 55(11):829-33.
PMID: 12401820
PMC: 1769808.
DOI: 10.1136/jcp.55.11.829.
Cisplatinum and taxol induce different patterns of p53 phosphorylation.
Damia G, Filiberti L, Vikhanskaya F, Carrassa L, Taya Y, DIncalci M
Neoplasia. 2001; 3(1):10-6.
PMID: 11326311
PMC: 1505020.
DOI: 10.1038/sj.neo.7900122.
Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation.
Rodriguez M, Desterro J, Lain S, Lane D, Hay R
Mol Cell Biol. 2000; 20(22):8458-67.
PMID: 11046142
PMC: 102152.
DOI: 10.1128/MCB.20.22.8458-8467.2000.
Nitric oxide-dependent activation of p53 suppresses bleomycin-induced apoptosis in the lung.
Davis D, Weidner D, Holian A, McConkey D
J Exp Med. 2000; 192(6):857-69.
PMID: 10993916
PMC: 2193293.
DOI: 10.1084/jem.192.6.857.
Adenovirus E1B 55-kilodalton oncoprotein inhibits p53 acetylation by PCAF.
Liu Y, Colosimo A, Yang X, Liao D
Mol Cell Biol. 2000; 20(15):5540-53.
PMID: 10891493
PMC: 86007.
DOI: 10.1128/MCB.20.15.5540-5553.2000.
The p53 response to DNA damage in vivo is independent of DNA-dependent protein kinase.
Jhappan C, Yusufzai T, Anderson S, Anver M, Merlino G
Mol Cell Biol. 2000; 20(11):4075-83.
PMID: 10805749
PMC: 85777.
DOI: 10.1128/MCB.20.11.4075-4083.2000.
Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer.
Michalides R
J Clin Pathol. 2000; 52(8):555-68.
PMID: 10645224
PMC: 500945.
DOI: 10.1136/jcp.52.8.555.
Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage.
Khosravi R, Maya R, Gottlieb T, Oren M, Shiloh Y, Shkedy D
Proc Natl Acad Sci U S A. 1999; 96(26):14973-7.
PMID: 10611322
PMC: 24757.
DOI: 10.1073/pnas.96.26.14973.
Double-stranded-RNA-activated protein kinase PKR enhances transcriptional activation by tumor suppressor p53.
Cuddihy A, Li S, Tam N, Wong A, Taya Y, Abraham N
Mol Cell Biol. 1999; 19(4):2475-84.
PMID: 10082513
PMC: 84040.
DOI: 10.1128/MCB.19.4.2475.
Semirational design of active tumor suppressor p53 DNA binding domain with enhanced stability.
Nikolova P, Henckel J, Lane D, Fersht A
Proc Natl Acad Sci U S A. 1998; 95(25):14675-80.
PMID: 9843948
PMC: 24508.
DOI: 10.1073/pnas.95.25.14675.
The TOR nutrient signalling pathway phosphorylates NPR1 and inhibits turnover of the tryptophan permease.
Schmidt A, Beck T, Koller A, Kunz J, Hall M
EMBO J. 1998; 17(23):6924-31.
PMID: 9843498
PMC: 1171040.
DOI: 10.1093/emboj/17.23.6924.
